A Placebo-Controlled, Double Blind Trial of Infliximab for Cancer-Associated Weight Loss in Elderly and/or Poor Performance Non-Small Cell Lung Cancer Patients (N01C9)
      QxMD      Google Scholar   
Citation:
Lung Cancer vol 68 (2) 234-239
Year:
2010
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                 
Networks:
 
Study
NCCTG-N01C9
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: